BioSpace News Archive

Septal Occluder Devices is indicated for percutaneous transcatheter closure of a patent foramen ovale to reduce the risk of recurrent ischemic stroke in patients. Patent foramen ovale defect is a highly common congenital cardiac disease that usually affects women more than men.

Intravenous filters or IV filters are the medical devices used for the removal of impurities in the IV solution or other medications.

High-content screening technologies have the ability of simultaneously studying multiple parameters in complex biological systems, a factor that is also one of the key factors driving the global market for high-content screening.

BiPAP, also known as bi-level positive airway pressure therapy, is a type of non-invasive ventilation which involves application of pressure while wearing a mask. The mask is connected to a machine that provides pressure.

As per a study by Fact.MR, the global BRAF-MEK inhibitors market is expected to grow due to increasing prevalence of cancer such as melanoma, metastatic, and colorectal cancer.

Prosit Sole Biotechnology, a clinical-stage biotech company developing novel protein therapeutics, announces that it has initiated the first-in-human Phase I clinical trial of PSP001 in US. PSP001 is a novel, long acting and potent interferon lambda chimera injection.

RadNet, Inc., a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, announced that Mark Stolper, Executive Vice President and Chief Financial Officer, will be presenting at the Jefferies 2021 Virtual Global Healthcare Conference on Thursday, June 3, 2021 at 2:30 p.m. Eastern Time.

Proven to improve glycemic control and can reduce the risk of costly long-term diabetes-related complications compared to fingerstick monitoring.

Heidelberg, Germany, May 26, 2021 – Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced today that its Chief Executive Officer, Dr. Adi Hoess, will present at the Jefferies Virtual Healthcare Conference on Wednesday, June 2, 2021 at 8:30 a.m. Eastern Time. A live webcast of the presentation will be accessible on Affimed’s website at https://www.affimed.com/investors/webcasts_cp/ . A replay of

TIAN RUIXIANG Holdings Ltd, a China-based insurance broker, announces that it has been commissioned by Zhongkang Yiyang Health Technology Co., Ltd., a company providing technology and health management related services, to develop and launch the “Zhongkang Huimin Cancer Prevention Insurance”, a specialty health insurance product relating to cancer prevention and treatment to be offered to residents in Mainland China.